| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.66B | +6.4% |
| Cost of Revenue | $196.3M | +2.6% |
| R&D Expense | $103.6M | +7.1% |
| SG&A Expense | $235.7M | +11.7% |
| Operating Income | $1.12B | +5.9% |
| Interest Expense | $77.0M | +2.3% |
| Pre-tax Income | $1.07B | +4.6% |
| Income Tax | $242.8M | +2.8% |
| Net Income | $825.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $307.9M | +49.0% |
| Short-term Investments | $272.6M | -30.7% |
| Accounts Receivable | $7.7M | +37.5% |
| Current Assets | $652.5M | -1.7% |
| Total Assets | $1.33B | -5.7% |
| Current Liabilities | $1.33B | -12.9% |
| Total Liabilities | $3.48B | +3.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.09B | +20.9% |
| Capital Expenditures | $22.8M | -18.9% |
| Investing Cash Flow | $109.1M | -61.9% |
| Financing Cash Flow | -$1.10B | +9.7% |
| Free Cash Flow | $1.07B | +22.2% |
| +5.1% |
| Stockholders' Equity |
| -$2.15B |
| -10.0% |